|
SNAP23 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.576970E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.096300E-02 |
| Normal-vs-Stage2 |
8.491600E-01 |
| Normal-vs-Stage3 |
8.283400E-01 |
| Normal-vs-Stage4 |
5.774600E-01 |
| Stage1-vs-Stage2 |
2.631600E-01 |
| Stage1-vs-Stage3 |
1.091620E-01 |
| Stage1-vs-Stage4 |
3.759800E-01 |
| Stage2-vs-Stage3 |
9.716000E-01 |
| Stage2-vs-Stage4 |
8.138600E-01 |
| Stage3-vs-Stage4 |
7.406600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.879230E-01 |
| Normal-vs-AfricanAmerican |
3.486800E-01 |
| Normal-vs-Asian |
3.607600E-01 |
| Caucasian-vs-AfricanAmerican |
9.041400E-01 |
| Caucasian-vs-Asian |
8.578800E-01 |
| AfricanAmerican-vs-Asian |
9.886600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.061200E-01 |
| Normal-vs-Female |
1.935020E-01 |
| Male-vs-Female |
8.004000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.576000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.941600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.810400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.579000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.446000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.177500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.249000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.094000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.675000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.502600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.119200E-01 |
| Classical-VS-Follicular |
8.216800E-01 |
| Classical-VS-Other |
6.256600E-01 |
| Classical-VS-Normal |
6.442300E-02 |
| Tall-VS-Follicular |
3.556800E-01 |
| Tall-VS-Other |
8.762600E-01 |
| Tall-VS-Normal |
9.634800E-01 |
| Follicular-VS-Other |
7.858800E-01 |
| Follicular-VS-Normal |
3.082200E-01 |
| Other-VS-Normal |
8.794800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.822200E-01 |
| Normal-vs-N1 |
9.795400E-01 |
| N0-vs-N1 |
3.643400E-01 |
|
|
